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Figure S1. Statistics of reads obtained from whole genome sequencing. (A) Ranges of GC content, 
duplication level and read quality scores of total reads over all samples (n=16, i.e., values for each lane 
of four samples) as well as mean read depth per base after mapping (n=4). (B) Average sequencing read 





Figure S2. Statistics of input reads obtained from whole genome bisulfite sequencing. Values for each 





Figure S3. Bisulfite conversion efficiency. (A) Base compositions on forward and reverse strand over all 






Figure S4. Quality measurements of deduplicated mapped reads obtained from whole genome bisulfite 
sequencing. (A) Ranges of GC content, read quality scores and duplication level of deduplicated 
mapped reads over all samples as well as mean read depth per base. (B) Average sequencing read depth 




Figure S5. Methylation bias and rates. (A) CpG methylation bias (M-bias) over forward and reverse 
reads over all bases. (B) Methylation rates over CpGs, CHGs, CHHs and Cs. Note that ‘H’ denotes for 





Figure S6. Filtering of possible disease-relevant local variations identified in affected TOF twins based 
on zygosity differences between healthy and affected sibling. CADD, combined annotation dependent 
depletion; H, healthy; INDEL, insertion and deletion; M, million; MAF, minor allele frequency; SNV, 




Figure S7. Filtering of possible disease-relevant structural variations identified in affected TOF twins 
using whole genome sequencing. H, healthy; TOF, Tetralogy of Fallot; SV, structural variation; VEP, 





Figure S8. Global DNA methylation levels of twins. Line plots show the DNA methylation along the 
chromosomal length (GRCh38.p13/hg38). (A) Methylation levels in Twin1_H and Twin1_TOF. (B) 





Figure S9. DNA methylation rate and coverage of CpGs. (A) Methylation and coverage in Twin1_H and 




















Twin1_H_TD180611543_HNCVWCCXY_L4_1 11.70% 40% 78.5 38.6 
Twin1_H_TD180611543_HNCVWCCXY_L4_2 10.50% 41% 78.5 37.2 
Twin1_H_TD180611543_HNCVWCCXY_L5_1 11.30% 40% 77.5 38.6 
Twin1_H_TD180611543_HNCVWCCXY_L5_2 10.70% 41% 77.5 37.2 
Twin1_H_TD180611543_HNCVWCCXY_L6_1 10.30% 40% 78.3 38.7 
Twin1_H_TD180611543_HNCVWCCXY_L6_2 10.30% 41% 78.3 37.3 
Twin1_H_TD180611543_HNCVWCCXY_L7_1 10.90% 40% 78.0 38.6 









Twin1_TOF_TD180611542_HNCVWCCXY_L4_1 10.70% 40% 79.6 38.6 
Twin1_TOF_TD180611542_HNCVWCCXY_L4_2 9.60% 41% 79.6 37.0 
Twin1_TOF_TD180611542_HNCVWCCXY_L5_1 10.10% 40% 79.0 38.6 
Twin1_TOF_TD180611542_HNCVWCCXY_L5_2 9.60% 41% 79.0 37.0 
Twin1_TOF_TD180611542_HNCVWCCXY_L6_1 9.30% 40% 79.8 38.6 
Twin1_TOF_TD180611542_HNCVWCCXY_L6_2 9.10% 41% 79.8 37.1 
Twin1_TOF_TD180611542_HNCVWCCXY_L7_1 9.90% 40% 79.4 38.6 







Twin2_H_TD180611545_HNCVWCCXY_L4_1 11.30% 40% 85.3 38.6 
Twin2_H_TD180611545_HNCVWCCXY_L4_2 10.20% 41% 85.3 37.2 
Twin2_H_TD180611545_HNCVWCCXY_L5_1 10.80% 40% 84.8 38.6 
Twin2_H_TD180611545_HNCVWCCXY_L5_2 10.20% 41% 84.8 37.2 
Twin2_H_TD180611545_HNCVWCCXY_L6_1 10.00% 40% 85.6 38.6 
Twin2_H_TD180611545_HNCVWCCXY_L6_2 9.90% 41% 85.6 37.3 
Twin2_H_TD180611545_HNCVWCCXY_L7_1 10.70% 40% 85.3 38.6 









Twin2_TOF_TD180611544_HNCVWCCXY_L4_1 11.70% 40% 89.7 38.7 
Twin2_TOF_TD180611544_HNCVWCCXY_L4_2 10.40% 40% 89.7 37.3 
Twin2_TOF_TD180611544_HNCVWCCXY_L5_1 11.40% 40% 89.1 38.6 
Twin2_TOF_TD180611544_HNCVWCCXY_L5_2 10.70% 40% 89.1 37.3 
Twin2_TOF_TD180611544_HNCVWCCXY_L6_1 10.70% 40% 90.0 38.7 
Twin2_TOF_TD180611544_HNCVWCCXY_L6_2 10.40% 40% 90.0 37.4 
Twin2_TOF_TD180611544_HNCVWCCXY_L7_1 11.20% 40% 89.7 38.6 
Twin2_TOF_TD180611544_HNCVWCCXY_L7_2 10.40% 40% 89.7 37.3 
 average 10.42% 40.4% 83.1 37.91 
 
Table S1. Overview of sequencing reads obtained from whole genome sequencing. Paired-end Illumina 
sequencing (2x150 bp) was performed. For each sample, 'L' denotes the sequencing lane and '*_1'/'*_2' 




  Twin1_H Twin1_TOF Twin2_H Twin2_TOF 
Total reads 623696038 (100%) 634620440 (100%) 681201156 (100%) 715910380 (100%) 
Duplicate 77812477 (12.5%) 71476214 (11.3%) 85443090 (12.5%) 92229860 (12.9%) 
Mapped reads 616017435 (98.8%) 627147782 (98.82%) 672959701 (98.8%) 707412206 (98.8%) 
PE mapped 612513294 (98.2%) 623523880 (98.3%) 669238718 (98.2%) 703618084 (98.2%) 
SE mapped 3504141 (0.6%) 3623902 (0.6%) 3720983 (0.5%) 3794122 (0.5%) 
Average 
sequencing depth 
28.25 28.76 30.87 32.45 
Coverage 99.82% 99.82% 99.21% 99.22% 
Coverage ≥4X 98.79% 98.79% 98.20% 98.25% 
Coverage ≥10X 96.28% 96.28% 96.31% 96.48 
 
Table S2. Statistics of read mapping, coverage and read depth in each sample obtained from whole 













Sp333_L1_1 10.7% 21% 60.7 38.61 
Sp333_L1_2 7.2% 21% 60.7 35.96 
Sp333_L2_1 10.8% 21% 60.9 38.59 
Sp333_L2_2 8.8% 21% 60.9 35.42 
Sp333_L3_1 11.1% 21% 61.5 38.62 
Sp333_L3_2 10.9% 21% 61.5 35.93 
Sp333_L4_1 11.4% 21% 60.7 38.59 
Sp333_L4_2 10.8% 21% 60.7 35.84 
Sp333_L5_1 11.4% 21% 60.8 38.57 
Sp333_L5_2 10.7% 21% 60.8 35.88 
Sp333_L6_1 11.6% 21% 60.8 38.59 







Sp334_L1_1 9.5% 21% 52.8 38.61 
Sp334_L1_2 6.9% 21% 52.8 35.28 
Sp334_L2_1 9.6% 21% 52.9 38.60 
Sp334_L2_2 7.9% 21% 52.9 34.74 
Sp334_L3_1 9.9% 21% 53.1 38.62 
Sp334_L3_2 9.3% 21% 53.1 35.21 
Sp334_L4_1 10.1% 21% 52.9 38.60 
Sp334_L4_2 9.4% 21% 52.9 35.11 
Sp334_L5_1 10.2% 21% 53.0 38.58 
Sp334_L5_2 9.4% 21% 53.0 35.16 
Sp334_L6_1 10.2% 21% 52.9 38.59 









Sp335_L1_1 9.9% 21% 58.1 38.57 
Sp335_L1_2 6.7% 21% 58.1 35.33 
Sp335_L2_1 10.3% 21% 58.4 38.56 
Sp335_L2_2 8.4% 21% 58.4 34.87 
Sp335_L3_1 10.5% 21% 58.5 38.58 
Sp335_L3_2 10.1% 21% 58.5 35.36 
Sp335_L4_1 10.8% 21% 58.1 38.56 
Sp335_L4_2 10.2% 21% 58.1 35.26 
Sp335_L5_1 10.8% 21% 58.2 38.53 
Sp335_L5_2 10.1% 21% 58.2 35.30 
Sp335_L6_1 10.9% 21% 58.2 38.55 







Sp336_L1_1 10.6% 21% 57.4 38.53 
Sp336_L1_2 7.3% 22% 57.4 35.32 
Sp336_L2_1 10.7% 21% 57.5 38.52 
Sp336_L2_2 8.7% 22% 57.5 34.81 
Sp336_L3_1 10.8% 21% 57.7 38.54 
Sp336_L3_2 10.3% 22% 57.7 35.30 
Sp336_L4_1 11.0% 21% 57.4 38.52 
Sp336_L4_2 10.3% 22% 57.4 35.20 
Sp336_L5_1 11.2% 21% 57.5 38.50 
Sp336_L5_2 10.3% 22% 57.5 35.25 
Sp336_L6_1 11.3% 21% 57.4 38.51 
Sp336_L6_2 10.2% 22% 57.4 35.15 
 average 10.0% 21.1% 57.4 36.95 
 
Table S3. Overview of sequencing reads obtained from whole genome bisulfite sequencing. Paired-end 
Illumina sequencing (2x150 bp) was performed. For each sample, 'L' denotes the sequencing lane and 


























Sp333_RDM00799_L1  60713900 47385992 11020584 2307323 5189315 42196677 
Sp333_RDM00799_L2   60893917 46199044 12445190 2249682 5134995 41064049 
Sp333_RDM00799_L3   61492618 47941470 11220346 2330802 5487141 42454329 
Sp333_RDM00799_L4   60709131 47151752 11261855 2295523 5388325 41763427 
Sp333_RDM00799_L5   60734267 47279615 11151329 2303322 5500015 41779600 







Sp334_RDM00800_L1   52811578 42765055 8112712 1933811 3788216 38976839 
Sp334_RDM00800_L2   52869973 41547389 9448694 1873888 3745131 37802258 
Sp334_RDM00800_L3   53073278 42862058 8277457 1933762 3975946 38886112 
Sp334_RDM00800_L4   52907527 42575157 8410260 1922110 3951599 38623558 
Sp334_RDM00800_L5   52970756 42740812 8298848 1931094 4042902 38697910 









Sp335_RDM00801_L1   58057558 43962495 11948026 2147033 4600494 39362001 
Sp335_RDM00801_L2   58331772 42931982 13304995 2094791 4569984 38361998 
Sp335_RDM00801_L3   58434542 44208796 12070948 2154794 4838393 39370403 
Sp335_RDM00801_L4   58102451 43793880 12175556 2133013 4789273 39004607 
Sp335_RDM00801_L5   58145454 43929444 12074280 2141726 4889574 39039870 







Sp336_RDM00802_L1   57337526 38671981 16656058 2009485 3765512 34906469 
Sp336_RDM00802_L2   57461325 37640382 17867931 1953011 3723665 33916717 
Sp336_RDM00802_L3   57656206 38835755 16807423 2013024 3947861 34887894 
Sp336_RDM00802_L4   57403215 38509393 16895107 1998711 3912006 34597387 
Sp336_RDM00802_L5   57474641 38653792 16814326 2006521 4003857 34649935 
Sp336_RDM00802_L6   57411843 38510060 16898712 2003071 4044545 34465515 
 
Table S4. Mapping result of reads obtained from whole genome bisulfite sequencing. For each sample, 





  Twin1_H Twin1_TOF Twin2_H Twin2_TOF 
Mean depth 24.0 22.1 22.4 19.8 
SD depth 37.31 37.57 36.59 43.77 
Mean mapping quality (Pred) 36.01 35.83 35.62 35.43 
Mean insert size (bp) 256.24 255.93 251.37 255.33 
SD insert size (bp) 54.78 56.80 55.08 56.77 
GC (%) 20.9 20.6 21.5 22.2 
Methylated CpG (%) 83.5 84.6 80.9 81.1 
Methylated CHG (%) 0.5 0.6 0.5 0.5 
Methylated CHH (%) 0.4 0.5 0.5 0.5 
Cs (million) 10504 9347 9875 8860 
Dups (%) 12.1 10.0 11.5 11.1 
Deduplicated reads (million) 249.1 229.5 232.4 205.2 
Duplicated reads (million) 34.1 25.5 30.3 25.6 
 
Table S5. Read statistics after mapping and deduplication as well as methylation rates over CpGs, 





Chr Start End 
Copy 









4 68550000 68600000 4 gain UGT2B17 
5 46450000 46500000 3 gain - 
7 38250000 38350000 3 gain 
TRGJ2, TRGJP2, TRGC1, TRGJ1, 
TRGJP, TARP 
9 60700000 60750000 3 gain - 
10 39650000 39700000 3 gain - 
13 86200000 86250000 3 gain - 
18 20850000 20900000 1 loss - 
19 54850000 54900000 3 gain KIR3DL2, FCAR 
21 5450000 5500000 3 gain - 
21 5800000 5850000 3 gain - 









1 228550000 228600000 3 gain RNA5SP19 
5 46450000 46500000 3 gain - 
14 41150000 41200000 1 loss - 
18 20850000 20900000 1 loss - 
 
Table S6. Copy number variations identified in Twin1_TOF and Twin2_TOF based on whole genome 





Table S7. Structural variations uniquely identified in Twin1_TOF based on whole genome sequencing 
data. Positions based human reference genome (GRCh38.p13/hg38).  
Chr Pos ID REF ALT Assoicated gene GT:FT:GQ:PL:PR(:SR)








chr1 16725226 MantaBND:616:0:1:0:0:0:0 A [chr1:234776356[A 0/1:MinGQ:12:62,0,821:55,17
chr1 205209478 MantaBND:6064:0:1:0:0:0:1 C CACAAC]chr1:205209646] DSTYK 0/1:PASS:203:339,0,200:9,2:18,7
chr1 205209646 MantaBND:6064:0:1:0:0:0:0 A AGTTGT]chr1:205209478] DSTYK 0/1:PASS:203:339,0,200:9,2:18,7






chr11 63931436 MantaDEL:60668:0:1:0:0:0 A <DEL> NAA40 0/1:PASS:348:576,0,345:10,6:25,12
chr13 36433387 MantaBND:68499:0:1:0:0:0:0 T ]chr22:17720154]T CCNA1 0/1:PASS:51:101,0,201:9,0:16,3

















chr20 24836274 MantaINS:88780:0:0:0:2:0 A <INS> 1/1:PASS:41:670,44,0:0,3:0,14















































chr7 154794795 MantaBND:45134:0:1:0:0:0:1 C C[chrX:24347205[ DPP6 0/1:PASS:112:198,0,109:9,12















Table S8. Structural variations uniquely identified in Twin2_TOF based on whole genome sequencing 
data. Positions based human reference genome (GRCh38.p13/hg38). 
  
Chr Pos ID REF ALT Assoicated gene GT:FT:GQ:PL:PR(:SR)






chr1 16725255 MantaBND:687:0:1:0:0:0:0 C [chr1:234776370[C 0/1:PASS:297:347,0,488:36,29
chr1 206923954 MantaDUP:TANDEM:6517:0:1:0:0:0 T <DUP:TANDEM> PIGR 0/1:PASS:30:80,0,593:19,4:34,5
chr11 63931436 MantaDEL:64286:0:1:0:0:0 A <DEL> NAA40 0/1:PASS:431:481,0,568:25,10:35,8




chr11 122084984 MantaDEL:66360:0:0:0:0:0 AAAAATATATATATATATATATATATAATATACATGATATATCATGTATAT ATATA MIR100HG 0/1:PASS:20:227,0,17:1,0:3,5
chr15 41559198 MantaBND:72779:0:2:0:0:0:0 C [chr13:43495691[GC TYRO3 0/1:PASS:195:245,0,488:10,7:25,5























chr6 24811647 MantaDEL:37456:0:1:0:0:0 T <DEL> RIPOR2 1/1:PASS:21:237,24,0:0,6:0,2





chr7 58064116 MantaBND:44429:0:1:0:1:0:1 A [chr16:36124088[A 0/1:PASS:304:376,0,301:13,6:19,43
chr7 151312872 MantaBND:47612:1:2:0:0:0:1 T [chr7:151315024[T 0/1:PASS:20:70,0,260:18,8
















  Gene Overlap 
Tissue             
(RV) 
iPSC-derived CMs         
(day 15) 










TOF       
(n=1, 2 
clones) 























 AL355377.3   0.0 0.0 0.0 0.0 0.0 0.0 
DFFB 1,4 2.6 3.9 7.3 8.7 4.4 2.7 
FTH1P20   0.0 0.0 4.4 3.7 6.4 6.0 
NAA40 3 6.0 9.2 14.2 20.4 14.5 13.7 









ANTXR1 2,3 4.5 9.9 24.7 29.5 64.7 24.9 
AVL9   2.1 1.9 6.2 6.1 4.3 3.0 
CCNA1   0.0 0.0 0.6 0.1 0.4 0.4 
DNAH17   0.2 0.2 0.5 0.4 0.2 0.3 
DPP6   0.1 0.1 0.4 0.4 0.1 0.3 
DSTYK   2.0 2.5 4.4 3.7 4.8 2.7 
GRM4 3 0.1 0.2 0.4 0.1 0.0 0.1 
KAZN 3 0.7 0.5 6.4 6.1 4.1 1.5 
L3MBTL4 2,3,4,6 0.2 1.2 4.5 2.6 4.5 3.4 
LINC01348   0.0 0.0 0.0 0.0 0.0 0.0 
NDUFA13 1 1836.7 1749.8 114.7 163.8 123.0 203.7 
PRDM15   1.3 1.0 2.5 3.1 2.1 1.5 
RETREG1   0.0 0.0 0.0 0.0 0.0 0.0 
SAMD10 4 2.4 1.9 2.0 1.6 1.2 1.6 









BBS2 1,3 7.1 8.6 54.6 45.0 34.2 34.2 
EIF2S3 1 13.0 18.3 184.1 110.4 121.5 52.3 
ERG   3.4 3.8 0.6 0.3 3.0 0.2 
GAK 4 7.0 7.5 17.1 20.1 12.3 10.6 
MIR100HG   3.7 7.0 2.0 1.6 2.5 0.6 
PIGR   0.7 0.8 0.1 0.0 0.0 0.0 
TENM4 3 0.1 0.1 8.8 7.2 3.5 1.7 
TYRO3   1.1 1.1 15.3 26.0 8.1 4.3 
 
Table S9. Candidate genes with structural variations in Twin1_TOF and/or Twin2_TOF. Expression is 
given in RPKM (tissue; Grunert et al. 2014) and TPM (CMs; Grunert et al. 2020) values, respectively. 
Overlap with list of cardiovascular-associated genes is indicated by ‘1’ and overlaps with CHD-related 
datasets are indicated by ‘2’ (expression), ‘3’ (methylation), ‘4’ (CNV), ‘5’ (CHD gene), and ‘6’ 
(miRtarget). CHD, congenital heart disease; CNV, copy number variation; CMs, cardiomyocytes; H, 
healthy; iPSC, induced pluripotent stem cell; NH, normal heart; RPKM, reads per kilo base per million 
mapped reads; RV, right ventricle; TOF, Tetralogy of Fallot; TPM, transcript per million. 
